New Key Statistics Module, Z-Score and F-Score
BJSE:839729 Key Ratios
Market Cap ¥ M | 1,891.58 |
Enterprise Value ¥ M | 1,893.22 |
P/E(ttm) | 58.54 |
PE Ratio without NRI | 45.99 |
Forward PE Ratio | -- |
Price/Book | 2.71 |
Price/Sales | 6.60 |
Price/Free Cash Flow | 24.21 |
Price/Owner Earnings | 411.25 |
Payout Ratio % | 1.29 |
Revenue (TTM) ¥ M | 261.00 |
EPS (TTM) ¥ | 0.11 |
Beneish M-Score | -3 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 1.50 |
y-y EBITDA Growth Rate % | -64.60 |
EV-to-EBIT | 54.27 |
EV-to-EBITDA | 54.27 |
PEG | 30.66 |
Shares Outstanding M | 273.35 |
Net Margin (%) | 11.19 |
Operating Margin % | 12.52 |
Pre-tax Margin (%) | 12.31 |
Quick Ratio | 4.28 |
Current Ratio | 4.51 |
ROA % (ttm) | 3.67 |
ROE % (ttm) | 4.44 |
ROIC % (ttm) | 5.22 |
Dividend Yield % | 2.59 |
Altman Z-Score | 9.14 |
BJSE:839729 Number of Guru Trades
BJSE:839729 Volume of Guru Trades
Gurus Latest Trades with BJSE:839729
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
BJSE:839729 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guangdong Winsun Bio Pharmaceutical Co Ltd Insider Transactions
No Available Data